AbbVie Looks To Ditch FCA Suit Alleging Humira Kickbacks
AbbVie Inc. has urged an Illinois federal judge to let it escape a False Claims Act suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira...To view the full article, register now.
Already a subscriber? Click here to view full article